-+ 0.00%
-+ 0.00%
-+ 0.00%

AMGEN SHARES DOWN 5.4% PREMARKET; RIVAL NOVARTIS CHOLESTEROL DRUG FAILS LATE-STAGE STUDY

Reuters·09/08/2026 08:27:24

Please log in to view news